Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05376241 · ClinicalTrials.gov registry record · Phase 2
Promoting Informed Choice for Breast Cancer Screening
A Phase 2 study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 2
- Development phase
- 637
- Enrollment target
NCT05376241: Completed Phase 2 study, sponsored by University of Colorado, Denver.
NCT05376241 is a Phase 2 study that has completed, run by University of Colorado, Denver. The registered enrollment target is 637 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (379% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05376241, a Phase 2 study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 637 participants
- Enrollment target
Study Summary
Identify the prevalence and predictors of reactance, self-exemption, disbelief, source derogation in reaction to evidence about mammography benefits and harms, and consequences for decision-making and trust.
Primary Outcome
In response to mammography evidence, feeling that the information is manipulative or biased. 4 questions total, each on a 7 point Likert scale, with mean scores that range from 1 to 5. Higher mean scores reflect greater reactance.
Interventions
- BEHAVIORAL Decision aid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 637 participants |
| Start Date | 2022-01-03 |
| Est. Completion | 2022-05-07 |
| Phase | Phase 2 |
What the finished NCT05376241 record still lists
NCT05376241 is an interventional study that assigns participants to a tested intervention. The registered 637 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (379% higher).
The record links to 0 conditions, and to 1 intervention - of which Decision aid is the first listed.
NCT05376241 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05376241 about?
NCT05376241 is a clinical study titled "Promoting Informed Choice for Breast Cancer Screening". Identify the prevalence and predictors of reactance, self-exemption, disbelief, source derogation in reaction to evidence about mammography benefits and harms, and consequences for decision-making and trust.
What is the current status of trial NCT05376241?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 637 participants. The study started on 2022-01-03. Estimated completion is 2022-05-07.
What interventions are being tested in trial NCT05376241?
The interventions under investigation include: Decision aid (BEHAVIORAL).
Who is sponsoring clinical trial NCT05376241?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05376241's enrollment target sits among peer trials
637 51st of 2000 higher than 1,950 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03821129 · 636 participants · NA
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
- NCT03478826 · 635 participants
Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)
- NCT04339699 · 640 participants · NA
NobleStitch EL STITCH Trial is a PFO Comparative Trial
- NCT04979338 · 640 participants · Phase 3
Development of Effective, Opioid Sparing Techniques for Peri-operative Pain Management of Transgender Patients Undergoing Gender Affirming Surgeries
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI